Genetic testing for Alpha 1 Antitrypsin Deficiency helps identify inherited variations in the SERPINA1 gene that affect the production or function of alpha 1 antitrypsin, a protein that protects the lungs from damage. This inherited condition may increase the risk of lung diseases, including emphysema, and liver problems. Testing can help confirm a diagnosis, identify genetic variants, and provide information about potential health risks for affected individuals and their relatives. Understanding the testing process, possible results, and the role of genetic counseling can help individuals make informed decisions about medical evaluation.
Genetic testing examines DNA to identify variations in the SERPINA1 gene, which provides instructions for producing alpha 1 antitrypsin. Certain variants can reduce the amount of protein produced or affect how it functions. The condition may be inherited when a person receives disease-associated variants from one or both parents.
Healthcare professionals may recommend testing when symptoms, laboratory findings, or family history suggest AAT deficiency. Testing may also help clarify the genetic status of relatives of someone with a confirmed diagnosis.
Common reasons for genetic testing include:
Unexplained lung disease: Individuals with early-onset emphysema or chronic obstructive pulmonary disease may be evaluated for AAT deficiency.
Liver abnormalities: Unexplained liver disease, including certain problems in children or adults, may prompt testing.
Family history: Close relatives of individuals with confirmed AAT deficiency may consider testing to understand their inherited risk.
Confirming a diagnosis: Genetic analysis can help identify specific SERPINA1 variants associated with the condition.
Testing may involve a blood sample or a cheek swab, depending on the laboratory method. Healthcare professionals may also measure the level of alpha 1 antitrypsin in the blood. Combining protein-level measurements with genetic analysis can provide a clearer understanding of the findings.
Genetic test results can identify different SERPINA1 variants, including those associated with normal protein production, reduced protein levels, or severely reduced protein function. Common variants include M, S, and Z. For example, the Pi*ZZ genotype is commonly associated with severe AAT deficiency, while Pi*MZ generally indicates carrier status with a potentially increased risk of lung disease, particularly with smoking exposure.
Results should be interpreted alongside symptoms, medical history, and other laboratory findings because genetic information alone does not predict exactly how severely a person will be affected.
Important considerations when reviewing results include:
Genetic variant identification: Results can clarify which variants are present and help establish whether AAT deficiency is likely.
Family testing: Relatives may benefit from discussing genetic testing with a healthcare professional because the condition is inherited.
Health monitoring: Depending on the findings, clinicians may recommend lung function assessment, liver evaluation, and appropriate follow-up.
Risk reduction: Avoiding smoking and limiting exposure to lung irritants can help reduce respiratory risks, especially for people with AAT deficiency.
Genetic counseling: Counseling can explain inheritance patterns, family implications, and the meaning of uncertain or unexpected results.
Genetic testing has limitations. Some tests examine only selected variants, so additional analysis may be necessary when results do not match clinical findings. A positive result also does not mean that a person will inevitably develop severe lung or liver disease.
Genetic testing for Alpha 1 Antitrypsin Deficiency provides valuable information about inherited variants and can support diagnosis, family risk assessment, and appropriate health monitoring. Understanding the testing process and interpreting results with qualified healthcare professionals can help individuals make informed decisions about their care. This article is intended for general informational and educational purposes only and does not provide medical services or replace professional medical advice.